GENE ONLINE|News &
Opinion
Blog

Cardiovascular Disease
Wegovy Expands Its Reach: First Weight-Loss Medication Approved to Reduce Cardiovascular Risk
2024-03-11
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
Geneticists Find Loss of Y Chromosome in Aging Males Increases Risk of Heart Failure
2022-07-20
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
Verve Cleared to Test Gene Editing Drug for Heart Disease in Humans
2022-05-12
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
Encouraging Performance of Cardiovascular Drug Vindicates Novartis’ $9.7 Billion Buyout Deal
2020-09-06
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
True to Analyst Predictions, Amarin’s Shares Crash Following Vascepa Patent Invalidation
2020-03-31
Peptide Therapeutics Market: Promise for a Painless Future
2020-03-18
Will Vascepa Receive a FDA Approval as a New Year Gift?
2019-12-02
2019 Asia-Pacific Extracellular Vesicles Conference Made the World-leading Experts Gathered in Taipei
2019-01-19
LATEST
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
2024-06-18
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
EVENT
Scroll to Top